Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Oncology Reports|June 19, 1998
First line chemotherapy in patients with brain metastases from non-small and small cell lung cancerD Tummarello, P Lippe, R Bracci, et al.
Journal of Hospice and Palliative Nursing : JHPN : the Official Journal of the Hospice and Palliative Nurses Association|February 12, 2022
Nursing Student Perceptions of End-of-Life Communication Competence: A Qualitative Descriptive StudyStephanie Jeffers, Megan P Lippe, Amanda Justice, et al.
The Gerontologist|February 14, 2023
Quality of Care at the End of Life: Applying the Intersection of Race and GenderZainab Suntai, Hyunjin Noh, Lewis Lee, et al.
Arzneimittel-Forschung|May 9, 1998
Enterohepatic recirculation of the new antihypertensive drug UP 269-6 in humans. A possible model to account for multiple plasma peaksY Plusquellec, R Arnaud, S Saivin, et al.
La Clinica Terapeutica|February 1, 1995
[Role of polychemoembolization in the treatment of primary and secondary tumors of the liver]F Recchia, G Passalacqua, S De Filippis, et al.
Anticancer Research|April 13, 2001
Advanced colorectal cancer in elderly patients: tolerance and efficacy of leucovorin and fluorouracil bolus plus continuous infusionR Mattioli, P Lippe, F Recchia, et al.
Journal of Chromatography|July 11, 1986
Digoxin and metabolites in urine and feces: a fluorescence derivatization--high-performance liquid chromatographic techniqueT A Shepard, J Hui, A Chandrasekaran, et al.
Minerva Medica|October 19, 2000
Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot studyP Lippe, R R Silva, L Giuliodori, et al.
Oncology|December 6, 2003
Elderly patients with advanced non-small cell lung cancer. A pase II study with weekly cisplatin and gemcitabineR Berardi, E Porfiri, M Scartozzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2005
High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancerR Mattioli, C Massacesi, F Recchia, et al.
Pageof 4